comparemela.com
Home
Live Updates
FDA Approval Sought for Use of TLX007-CDx in PSMA PET Imaging of Prostate Cancer : comparemela.com
FDA Approval Sought for Use of TLX007-CDx in PSMA PET Imaging of Prostate Cancer
The FDA has received a new drug application for the use of TLX007-CDx in the preparation of PSMA PET imaging of prostate cancer.
Related Keywords
Canada ,
Australia ,
United States ,
Australian ,
Mike Crosby ,
Christian Behrenbruch ,
Cdx Illuccix ,
Telix Illuccix ,
Australian Therapeutic Goods Administration ,
Health Canada ,
Telix Pharmaceuticals ,
Veterans Prostate Cancer Awareness ,
comparemela.com © 2020. All Rights Reserved.